Literature DB >> 24680570

The migrated liver transplantation candidate: insight into geographic disparities in liver distribution.

Rachel Kohn1, Johannes R Kratz2, James F Markmann2, Parsia A Vagefi3.   

Abstract

BACKGROUND: A minority of liver transplantation (LT) candidates pursue listing at multiple centers to achieve transplantation. The purpose of this study was to assess the characteristics and outcomes of the migrated LT candidates, that is, those who travel to secondary centers seeking LT. STUDY
DESIGN: Single-center retrospective study from January 1, 2005 to January 1, 2013 at a tertiary care center within United Network for Organ Sharing Region 1. Adult recipients who were listed at the primary center of interest, but subsequently achieved transplantation at a secondary center (Massachusetts General Hospital [MGH]-migrated; n = 44) were compared with recipients who achieved LT at the primary center (MGH-transplanted; n = 279).
RESULTS: The MGH-migrated recipients most frequently traveled to United Network for Organ Sharing Region 3 (70.5%), with a mean (±SD) distance traveled of 1,134 (±392) miles. The MGH-migrated patients, when compared with MGH-transplanted recipients, spent more time on the waitlist (907.6 ± 930.1 days vs 354.9 ± 533.2 days; p < 0.00001), were more likely to have cholestatic liver disease (22.7% vs 6.8%; p = 0.0006) and private insurance (80.0% vs 51.6%; p = 0.0005), but were less likely to have alcoholic liver disease (2.3% vs 18.6%; p = 0.006) and Model for End-Stage Liver Disease exception points (6.8% vs 50.9%; p < 0.00001). On multivariable analysis, candidates with private insurance who lacked both alcoholic liver disease and Model for End-Stage Liver Disease exception point listing were significantly associated with the odds of pursuing migration. Despite achieving LT, MGH-migrated patients had inferior 5-year patient survival rates (63% vs 80%; p = 0.03).
CONCLUSIONS: A small and distinctive cohort of LT recipients pursue migration to achieve transplantation. Travel patterns of migrated LT recipients appear to reflect the ongoing geographic disparities in liver distribution and underscore the need for alterations in policy to allow for equitable distribution.
Copyright © 2014 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24680570     DOI: 10.1016/j.jamcollsurg.2013.12.056

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  Geographic disparities in liver supply/demand ratio within fixed-distance and fixed-population circles.

Authors:  Christine E Haugen; Tanveen Ishaque; Abel Sapirstein; Alexander Cauneac; Dorry L Segev; Sommer Gentry
Journal:  Am J Transplant       Date:  2019-03-18       Impact factor: 8.086

Review 2.  Travel for Transplantation: A Review of Domestic and International Travel for Liver Transplantation in the United States.

Authors:  Hillary J Braun; Nancy L Ascher
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-12-07

3.  Multiple listing in lung transplant candidates: A cohort study.

Authors:  Joshua J Mooney; Lingyao Yang; Haley Hedlin; Paul Mohabir; Gundeep S Dhillon
Journal:  Am J Transplant       Date:  2018-10-16       Impact factor: 8.086

4.  Patient Travel Distance and Post Lung Transplant Survival in the United States: A Cohort Study.

Authors:  Wayne M Tsuang; Susana Arrigain; Rocio Lopez; Megan Snair; Marie Budev; Jesse D Schold
Journal:  Transplantation       Date:  2020-11       Impact factor: 5.385

5.  Patterns and Outcomes Associated with Patient Migration for Liver Transplantation in the United States.

Authors:  Kristopher P Croome; David D Lee; Justin M Burns; Dana K Perry; Andrew P Keaveny; C Burcin Taner
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

Review 6.  A scoping review of inequities in access to organ transplant in the United States.

Authors:  Christine Park; Mandisa-Maia Jones; Samantha Kaplan; Felicitas L Koller; Julius M Wilder; L Ebony Boulware; Lisa M McElroy
Journal:  Int J Equity Health       Date:  2022-02-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.